Creative cost-effectiveness analysis of CAPRIE data - Dust in our eyes [3] (multiple letters)

American Journal of Medicine

Volumn 118, Issue 2, 2005, Pages 199-200

  Eriksson, Peter ^a   Schleinitz, Mark D ^b   Owens, Douglas K ^c  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b BROWN UNIVERSITY   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; HEART INFARCTION; HUMAN; LETTER; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK REDUCTION; STROKE; TREATMENT OUTCOME;

EID: 13444267367     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.11.013     Document Type: Letter

References (0)